CYP1B1 nucleic acids and methods of use
Details for Australian Patent Application No. 2002239410 (hide)
International Classifications
Event Publications
1 May 2008 Application Accepted
Published as AU-B-2002239410
7 August 2008 Alteration of Name
The name of the applicant has been altered to MGI PHARMA Biologics, Inc.
28 August 2008 Standard Patent Sealed
30 April 2009 Assignment Registered
MGI PHARMA Biologics, Inc. The patent has been assigned to Eisai Corporation of North America
29 October 2009 Assignment Registered
Eisai Corporation of North America The patent has been assigned to Eisai Inc.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002239409-COMPOSITIONS AND METHODS RELATING TO COLON SPECIFIC GENES AND PROTEINS
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser